Stock events for Mirion Technologies, Inc. (MIR)
Over the past six months, Mirion Technologies' stock has experienced fluctuations influenced by earnings reports and strategic acquisitions. The company's stock price reached an all-time high of $29.75 on October 29, 2025, and its 52-week high is $30.28, but has been falling recently, with a closing price of $21.33 as of March 5, 2026. A significant event was the Q4 2025 earnings report on February 10, 2026, where Mirion Technologies reported adjusted earnings per share of $0.15, missing the analyst consensus of $0.16. Revenue for the quarter was $277.4 million, slightly below the consensus estimate of $278.85 million, despite a 9.1% increase year-over-year. Despite the miss, the company highlighted record orders of over $1 billion in 2025, driven by strong tailwinds in nuclear power and nuclear medicine. Mirion also provided guidance for fiscal year 2026, projecting total revenue growth between 22.0% and 24.0%, with organic revenue growth between 5.0% and 7.0%. Strategic acquisitions have also impacted the company's outlook, including Certrec in July 2025 and Paragon Energy Solutions in December 2025.
Demand Seasonality affecting Mirion Technologies, Inc.’s stock price
Mirion Technologies experiences demand seasonality for its products and services, with the first and third quarters typically lighter in terms of volumes compared to the second and fourth quarters. This seasonality is particularly noticeable in the nuclear power business, aligning with the "outer season" for that sector.
Overview of Mirion Technologies, Inc.’s business
Mirion Technologies, Inc. (MIR) is a global leader in providing radiation detection and measurement solutions across various critical industries, operating in the Industrials sector, specifically within the Specialty Industrial Machinery industry. The company specializes in radiation safety, science, and medicine, offering products, services, and software that enable customers to safely utilize ionizing radiation. Mirion's operations are divided into two primary segments: Medical and Nuclear & Safety. The Medical segment focuses on improving the quality and safety of cancer care delivery and supporting applications in medical diagnostics and practitioner safety. The Nuclear & Safety segment addresses critical radiation safety, measurement, and analysis applications, powering advancements in nuclear energy and serving laboratories, research, and other industrial markets such as defense.
MIR’s Geographic footprint
Mirion Technologies, Inc. has a robust market presence across North America, Europe, and Asia, serving a broad customer base that includes government agencies, utility companies, research institutions, and healthcare providers. The company employs approximately 2,800 people and operates in 12 countries.
MIR Corporate Image Assessment
Mirion Technologies maintains a strong brand reputation as a global leader and trusted partner in radiation safety and management. The company's mission to empower customers with unparalleled insight into radiation environments and ensure operational integrity has solidified its standing. In May 2023, Mirion updated its corporate branding, with the overall corporate entity now branded simply as "Mirion," and the Industrial segment taking the name "Mirion Technologies."
Ownership
Mirion Technologies' ownership is primarily held by institutional investors. As of February 27, 2026, the company had 544 institutional owners holding a total of 268,144,495 shares. Major institutional owners include BlackRock, Inc., Vanguard Group Inc., and State Street Corp. Significant individual and insider owners include Gs Sponsor II LLC, Charterhouse General Partners IX Ltd, Thomas D. Logan (CEO and Chairman), and Leon G. Cooperman.
